drug

Benperidol

MeSH D001544
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Hannover Medical School
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

2
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
NCT02307396Phase 4Completed

KOLs & investigators

3
Stefan Leucht, ProfessorKOL score 87
Helge Frieling, Prof., MDKOL score 5
Markus Dold, MD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Hannover Medical School
company
trial
Pharmacovigilance in Gerontopsychiatric Patients
PHASE3
trial
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
PHASE4
trial
indication
Schizophrenia
indication
Depression
indication
Psychosomatic Disorders
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
KOL
Stefan Leucht, Professor
KOL score 87
person
Helge Frieling, Prof., MD
KOL score 5
person
Markus Dold, MD
KOL score —
person